651 - 700 of 6230 Results
Title
Year
- Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease Carriers2017OPENTitle: Patients’ Opinions on Genetic Counseling on the Increased Risk of Parkinson Disease among Gaucher Disease CarriersJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 27Issue #: 3Start Page: 675End Page: 680Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0161-0Best OA location URL: https://europepmc.org/articles/pmc5878114?pdf=renderCitation Count: 20
- β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling Pathway2011OPENTitle: β2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling PathwayJournal Name: The Journal of ImmunologyPublisher: Oxford University Press (OUP)Vol: 186Issue #: 7Start Page: 4443End Page: 4454Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.1002449Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/186/7/4443/1340946/1002449.pdfCitation Count: 116
-
OPENTitle: A Role for Neuronal Alpha-Synuclein in Gastrointestinal ImmunityJournal Name: Journal of Innate ImmunityPublisher: S. Karger AGVol: 9Issue #: 5Start Page: 456End Page: 463Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000477990Best OA location URL: https://www.karger.com/Article/Pdf/477990Citation Count: 252
-
OPENTitle: Apathy and Depression: Separate Factors in Parkinson's DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 17Issue #: 6Start Page: 1058End Page: 1066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617711001068Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3302577Citation Count: 130
- Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study2017OPENTitle: Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological StudyJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 23Issue #: 4Start Page: 322End Page: 331Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717000017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5729910Citation Count: 19
-
OPENTitle: Everyday Action Impairment in Parkinson's Disease DementiaJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 18Issue #: 5Start Page: 787End Page: 798Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s135561771200046xCitation Count: 45
- Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson’s Disease2017OPENTitle: Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 24Issue #: 3Start Page: 269End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717001011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5820218Citation Count: 19
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease2010OPENTitle: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 120Issue #: 8Start Page: 2745End Page: 2754Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci42642Best OA location URL: http://www.jci.org/articles/view/42642/files/pdfCitation Count: 404
-
OPENTitle: A brain network response to sham surgeryJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 8Start Page: 3285End Page: 3288Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci77193Best OA location URL: http://www.jci.org/articles/view/77193/files/pdfCitation Count: 5
-
OPENTitle: Remote control of induced dopaminergic neurons in parkinsonian ratsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 7Start Page: 3215End Page: 3229Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci74664Best OA location URL: http://www.jci.org/articles/view/74664/files/pdfCitation Count: 118
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients2014OPENTitle: Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 3Start Page: 1340End Page: 1349Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci71640Best OA location URL: http://www.jci.org/articles/view/71640/files/pdfCitation Count: 236
-
OPENTitle: Can Parkinson’s disease be cured by stimulating neurogenesis?Journal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 3Start Page: 978End Page: 980Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci80822Best OA location URL: http://www.jci.org/articles/view/80822/files/pdfCitation Count: 10
- Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients2011OPENTitle: Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 3Start Page: 930End Page: 940Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci43871Best OA location URL: http://www.jci.org/articles/view/43871/files/pdfCitation Count: 152
- Cerebrospinal fluid–based kinetic biomarkers of axonal transport in monitoring neurodegeneration2012OPENTitle: Cerebrospinal fluid–based kinetic biomarkers of axonal transport in monitoring neurodegenerationJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 122Issue #: 9Start Page: 3159End Page: 3169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci64575Citation Count: 57
-
OPENTitle: Clinical signs in functional (psychogenic) gait disorders: a brief surveyJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0031-1Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/counter/pdf/10.1186/s40734-016-0031-1Citation Count: 23
-
OPENTitle: Cautionary optimism: caffeine and Parkinson’s disease riskJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0037-8Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-016-0037-8Citation Count: 5
-
OPENTitle: Parkinson disease in Gaucher diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0054-2Best OA location URL: http://link.springer.com/content/pdf/10.1186/s40734-017-0054-2.pdfCitation Count: 14
- Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease2009OPENTitle: Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative diseaseJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 515Issue #: 3Start Page: 269End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.22040Best OA location URL: http://doi.org/10.1002/cne.22040Citation Count: 54
- Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities2020OPENTitle: Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal AbnormalitiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 5Start Page: 867End Page: 877Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/ana.25879Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25879Citation Count: 92
- Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy2013OPENTitle: Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid ImmunotherapyJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 3Start Page: e59735End Page: e59735Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0059735Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0059735&type=printableCitation Count: 34
-
OPENTitle: Short- and Long-Term Effects of LRRK2 on Axon and Dendrite GrowthJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61986End Page: e61986Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061986Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061986&type=printableCitation Count: 48
- Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model2013OPENTitle: Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 5Start Page: e65129End Page: e65129Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0065129Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0065129&type=printableCitation Count: 72
- Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the Brain2013OPENTitle: Permeabilization of the Blood-Brain Barrier via Mucosal Engrafting: Implications for Drug Delivery to the BrainJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61694End Page: e61694Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061694Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061694&type=printableCitation Count: 37
- Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model2013OPENTitle: Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61700End Page: e61700Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061700Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061700&type=printableCitation Count: 117
- Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease2016OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5410378Citation Count: 25
-
OPENTitle: Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasmJournal Name: Protein Engineering, Design and SelectionPublisher: Oxford University Press (OUP)Vol: 23Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/protein/gzq022Best OA location URL: https://academic.oup.com/peds/article-pdf/23/6/489/17494272/gzq022.pdfCitation Count: 58
-
OPENTitle: mzStudio: A Dynamic Digital Canvas for User-Driven Interrogation of Mass Spectrometry DataJournal Name: ProteomesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/proteomes5030020Best OA location URL: https://www.mdpi.com/2227-7382/5/3/20/pdf?version=1501590909Citation Count: 25
- Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease2008OPENTitle: Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseaseJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 2Issue #: 10-11Start Page: 1484End Page: 1497Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/prca.200800043Best OA location URL: https://europepmc.org/articles/pmc3142616?pdf=renderCitation Count: 27
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?2010OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
- Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing2013OPENTitle: Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencingJournal Name: RNAPublisher: Cold Spring Harbor LaboratoryVol: 19Issue #: 5Start Page: 712End Page: 722Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1261/rna.036863.112Best OA location URL: http://rnajournal.cshlp.org/content/19/5/712.full.pdfCitation Count: 187
-
OPENTitle: CNTRICS Imaging Biomarkers Final Task Selection: Long-Term Memory and Reinforcement LearningJournal Name: Schizophrenia BulletinPublisher: Oxford University Press (OUP)Vol: 38Issue #: 1Start Page: 62End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/schbul/sbr168Best OA location URL: https://academic.oup.com/schizophreniabulletin/article-pdf/38/1/62/5351297/sbr168.pdfCitation Count: 28
-
OPENTitle: Caffeine and risk of Parkinson's disease in a large cohort of men and womenJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 10Start Page: 1276End Page: 1282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25076Citation Count: 183
-
OPENTitle: Mood and cognition in leucine‐rich repeat kinase 2 G2019S Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 10Start Page: 1875End Page: 1880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23746Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3972755Citation Count: 40
- Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients2013OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859714Citation Count: 7
-
OPENTitle: Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 1966End Page: 1971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25647Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859844Citation Count: 136
- Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implications2013OPENTitle: Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implicationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 9Start Page: 1301End Page: 1304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25496Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3760996Citation Count: 38
-
OPENTitle: Caffeine consumption and risk of dyskinesia in CALM‐PDJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 380End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3608707Citation Count: 54
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia2012OPENTitle: β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementiaJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 296End Page: 301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25213Best OA location URL: https://hdl.handle.net/2027.42/97160Citation Count: 87
-
OPENTitle: Disease‐related and genetic correlates of psychotic symptoms in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2190End Page: 2195Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23806Best OA location URL: http://doi.org/10.1002/mds.23806Citation Count: 69
-
OPENTitle: Metabolomics and the search for biomarkers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1620End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25644Best OA location URL: http://doi.org/10.1002/mds.25644Citation Count: 10
-
OPENTitle: Reliability of a new scale for essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 12Start Page: 1567End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25162Citation Count: 205
-
OPENTitle: Maladaptive striatal plasticity in l-DOPA-induced dyskinesiaJournal Name: Progress in Brain ResearchPublisher: ElsevierVol:Issue #:Start Page: 209End Page: 233Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0079-6123(10)83011-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2930606Citation Count: 198
-
OPENTitle: MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms4633Best OA location URL: https://www.nature.com/articles/ncomms4633.pdfCitation Count: 282
- Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells2012OPENTitle: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cellsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms1669Best OA location URL: https://www.nature.com/articles/ncomms1669.pdfCitation Count: 241
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978804Citation Count: 23
-
OPENTitle: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms1085Best OA location URL: https://www.nature.com/articles/ncomms1085.pdfCitation Count: 151
-
OPENTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3140626Citation Count: 8
-
OPENTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
-
OPENTitle: The relationship between uric acid levels and Huntington's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 2Start Page: 224End Page: 228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22907Citation Count: 92
-
OPENTitle: Heart rate changes during freezing of gait in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 14Start Page: 2346End Page: 2354Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23280Best OA location URL: https://europepmc.org/articles/pmc2964413?pdf=renderCitation Count: 58